IDEAYA Biosciences Raises $94 Million Crossover Series B Financing

March 15, 2018

Responsive image

SOUTH SAN FRANCISCO, Calif., March 15, 2018 /PRNewswire/ — IDEAYA Biosciences, Inc., an oncology-focused biotechnology company committed to the discovery of breakthrough synthetic lethality medicines and immuno-oncology therapies, announced today the successful completion of a $94…

Category: Precious Metals